Ci Investments Inc. Moderna, Inc. Transaction History

Ci Investments Inc.

$25.4 Billion
Q2 2024

A detailed history of Ci Investments Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 9,582 shares of MRNA stock, worth $630,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,582

Previous 10,797 11.25%

Holding current value

$630,016

Previous $1.15 Million 1.13%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$101.21 - $166.61 $122,970 - $202,431	-1,215 Reduced 11.25%	9,582 $1.14 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $351,553 - $475,381	4,118 Added 61.66%	10,797 $1.15 Million
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $46,224 - $69,445	-665 Reduced 9.06%	6,679 $664,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $90,914 - $119,393	-943 Reduced 11.38%	7,344 $759,000
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $454,803 - $616,114	3,838 Added 86.27%	8,287 $1.01 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $319,750 - $464,376	2,357 Added 112.67%	4,449 $683,000
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $118,261 - $209,829	999 Added 91.4%	2,092 $376,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $106,971 - $175,927	-906 Reduced 45.32%	1,093 $129,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $144,655 - $218,088	-1,235 Reduced 38.19%	1,999 $286,000
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $171,732 - $319,197	1,358 Added 72.39%	3,234 $557,000
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $77,456 - $126,398	343 Added 22.37%	1,876 $476,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $340,172 - $742,692	1,533 New	1,533 $590,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Moderna, Inc. Transaction History